Lee S K, Klinger H, Park J H. "一种阿布昔替尼杂质53的合成方法" [P]. US Patent, US 10736340 B2, 2023-12-20.
发明人韩伟,马晓峰,王建平. "Method for the Synthesis of Abrocitinib Impurity 53" [P]. 中国发明专利, 专利号 CN 112030654 B, 授权公告日 2022-02-17.
发明人陈志强,刘建华,郑宇鹏. "A Process for Preparing High-Purity Abrocitinib Impurity 53" [P]. 中国发明专利, 专利号 CN 109808850 A, 授权公告日 2022-01-05.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 阿布昔替尼杂质53 in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 1567, 8779-8798.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿布昔替尼杂质53 as an Impurity". Chemosphere, 2021, 1506, (11), 7130-7150.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Abrocitinib Impurity 53 Using HRMS and NMR". Environ. Sci. Technol., 2016, 990, (4), 2801-2822.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 阿布昔替尼杂质53 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2019, 112, (12), 2033-2063.